Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMPAGLIFLOZIN vs EMTRICITABINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMPAGLIFLOZIN vs EMTRICITABINE: Safety Overview

Metric EMPAGLIFLOZIN EMTRICITABINE
Total FAERS Reports 37,059 3,718
Deaths Reported 1,624 499
Death Rate 4.4% 13.4%
Hospitalizations 12,216 797
Average Patient Age 64.3 yrs 42.2 yrs
% Female Patients 46.0% 41.9%
FDA Approval Date Aug 1, 2014 Jul 2, 2003
Manufacturer Cardinal Health 107, LLC Gilead Sciences, Inc
Route ORAL ORAL
Marketing Status Prescription Prescription